Brief: Pieris Pharmaceuticals Reports FY 2022 Net Loss Of $0.45 Per Share

Palvella Therapeutics

29/03/2023 12:55

March 29 (Reuters) - Pieris Pharmaceuticals Inc
 PIRS.O :
    * PIERIS PHARMACEUTICALS INC - NET LOSS WAS $33.3 MILLION OR
$0.45
PER SHARE FOR YEAR ENDED DECEMBER 31, 2022
    * PIERIS PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS, AND
INVESTMENTS TOTALED $59.2 MILLION FOR YEAR ENDED DECEMBER 31,
2022
    * PIERIS PHARMACEUTICALS INC - BELIEVES OPERATIONS ARE
SUFFICIENTLY FUNDED FOR MORE THAN NEXT 12 MONTHS
    * PIERIS PHARMACEUTICALS-ELAREKIBEP (PRS-060/AZD1402) PHASE
2A
STUDY FOR ASTHMA CONTINUES TO BE ENROLLED BY ASTRAZENECA;
CLINICAL DATA ANTICIPATED BY MID-2024

Further company coverage:  PIRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))